Mark Ormiston
Assistant Professor
Department of Biomedical And Molecular Sciences
Queens University
United Kingdom
Biography
Mark Ormiston is currently working as Assistant Professor of Biomedical And Molecular Sciences, Queens University. He has authored and co-authored multiple Peer-reviewed scientific papers and presented works at many national and International conferences.
Research Interest
His research is centered on the cellular mechanisms governing vascular remodeling in health and disease, with a particular focus on the capacity of circulating cells of the immune system to regulate blood vessel integrity, growth and repair.
Publications
-
Ormiston ML, Deng Y, Rundle N, Bendjelloul F, Tsoporis JN, Parker TG, Stewart DJ, Courtman DW. A lymphocyte-dependent mode of action for imatinib mesylate in experimental pulmonary hypertension. Am J Pathol. 2013 May;182(5):1541-51.
-
Long L, Ormiston ML (joint first author), Yang X, Southwood M, Gräf S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, Moore SD, Drake KM, Aldred MA, Yu PB, Upton PD, Morrell NW. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015 Jun 15.
-
Hong Z, Chen KH, Dasgupta A, Potus F, Dunham-Snary K, Bonnet S, Tian L, Fu J, Breuils-Bonnet S, Provencher S, Wu D, Mewburn J, Ormiston ML, Archer SL. miR-138 and miR-25 downregulate MCU, causing pulmonary arterial hypertension's cancer phenotype. Am J Respir Crit Care Med. 2016 Sep 20.
